Actualités Ivz Sp Eqw A - SPEX | Actions London Stock Exchange

Outils de qualité professionnelle, pour des investisseurs individuels.

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP 30 April 2021 NAV/per Shares in Net Asset share Funds Date ISIN code Issue Currency Value Base Invesco S&P...

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP 28 April 2021 NAV/per Shares in Net Asset share Funds Date ISIN code Issue Currency Value Base Invesco S&P...

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP 28 April 2021 NAV/per Shares in Net Asset share Funds Date ISIN code Issue Currency Value Base Invesco S&P...

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP 19 April 2021 NAV/per Shares in Net Asset share Funds Date ISIN code Issue Currency Value Base Invesco S&P...

Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes

Company Signs Long-term Supply Agreement for Pharmaceutical D-tagatose BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Spherix Inc. (Nasdaq...

Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco

BETHESDA, Md., Jan. 11 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider...

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a...

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a...

Spherix Announces Results of Annual Shareholders Meeting

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a...

Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development

BETHESDA, Md., Sept 10 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a...

Spherix Incorporated to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

BETHESDA, Md., Sept. 3 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider...

Spherix Announces Positive Phase 2 Study Results

Preliminary Data Demonstrates Reduction of HbA1c Levels With Doses an Order of Magnitude Lower than the Dose Used in the Current Phase 3 Trial...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Abonnez-vous à un compte ADVFN en remplissant le formulaire ci-dessous!

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ivz Sp Eqw A (SPEX)

Outils de qualité professionnelle, pour des investisseurs individuels.

SPEX Actualités

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes

Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

Spherix Announces Results of Annual Shareholders Meeting

Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development

Spherix Incorporated to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

Spherix Announces Positive Phase 2 Study Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ivz Sp Eqw A (SPEX) Actualités

Ivz Sp Eqw A (SPEX)

Outils de qualité professionnelle, pour des investisseurs individuels.

SPEX Actualités

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes

Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

Spherix Announces Results of Annual Shareholders Meeting

Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development

Spherix Incorporated to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

Spherix Announces Positive Phase 2 Study Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Abonnez-vous à un compte ADVFN en remplissant le formulaire ci-dessous!

Supprimer les publicités